DexCom, Inc.
DXCM Healthcare Medical Devices
DexCom, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.7 billion, up 15.6% from fiscal 2024. In the quarter to June 2026, revenue grew 13.1%, EPS grew 41.3%, free cash flow fell 11.7% and total debt was flat, each against the same quarter a year earlier. Member of the S&P 500 and Nasdaq 100; revenue growth for ten consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow DXCM
DexCom, Inc. (DXCM) EV/FCF
As of 16 October 2026, DexCom, Inc. (DXCM) trades at a EV/FCF of 23.5×. Over the past ten years it has ranged from −2,702× (December 2017) to 14,049× (January 2017); the current reading is higher than 20% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 24.1× | (49.50%) |
| FY2024 | 47.6× | (49.20%) |
| FY2023 | 93.8× | (35.35%) |
| FY2022 | 145× | 670.12% |
| FY2021 | 18.8× | (84.62%) |
| FY2020 | 122× | (15.41%) |
| FY2019 | 145× | (20.33%) |
| FY2018 | 182× | (1.30%) |
| FY2017 | 184× | (98.06%) |
| FY2016 | 9,495× | 2,220.17% |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 18.4× | 10.40% |
| Mar 2026 | 16.6× | (30.83%) |
| Dec 2025 | 24.1× | 2.15% |
| Sep 2025 | 23.5× | (59.64%) |
| 42 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| SNN Smith & Nephew SNATS, Inc. compare | 7.7× |
| PHG Koninklijke Philips N.V. compare | 16.1× |
| BSX Boston Scientific Corporation compare | 21.3× |
| DXCM DexCom, Inc. | 23.5× |
| ZBH Zimmer Biomet Holdings, Inc. compare | 24.4× |
| STE STERIS plc compare | 24.7× |
| GEHC GE HealthCare Technologies Inc. compare | 25.9× |
| EW Edwards Lifesciences Corporation compare | 33.4× |
| PEN Penumbra, Inc. compare | 55.5× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on DXCM
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement